Use of Lactobacillus rhamnosus GG Agaist Infection with Secondary Hydatid Disease in Swiss BABA/c Mice

Artículo

Use of Lactobacillus rhamnosus GG Agaist Infection with Secondary Hydatid Disease in Swiss BABA/c Mice

Tasneem Torki et al · University of Mosul, College of Education for Pure Science · 2019

Acceso abierto al texto completo

Lectura rápida. Revisá los datos básicos del recurso y luego accedé al contenido desde el botón principal. En esta ficha solo se muestra la información necesaria para identificar la obra, citarla y abrirla.

Autor / responsable

Tasneem Torki et al

Editorial

University of Mosul, College of Education for Pure Science

Año

2019

ISSN

1812-125X

ISSN

1812-125X

Idioma

eng

Publicación seriada

A Comparative Study Between Lipid A Extracted from Salmonella typhi and Pseudomonas Aeruginosa to Demonstrate the Extent of its Stimulation of Immune System

Esta publicación seriada contiene 109 contenidos relacionados.

Ver contenidos

Acceso al recurso

Entrá al contenido desde la opción principal o elegí otra fuente disponible.

Acceso principal

Acceso abierto al texto completo

Texto completo identificado como acceso abierto.

Abrir texto

Resumen

Descripción general del contenido del recurso.

The present study investigated the effect of probiotic bacteria lactobacillus GG (13×105 CFU/0.1ml) on the immune response of Swiss BALB/c mice (injected intraperitoneally), against experimental Infection with protoscoleces of Echinococcus granulosus (Postinfection), in comparison with the control group (mice injected with protoscoleces only) for 2-5 months. Another experimental group of mice inoculated (orally) with L.rhamnosus GG (8×107 CFU/0.1ml) preinfection with protoscoleces for 3 months. Depending on many criteria including numbers, weights, diameters of developed hydtid cysts, and the percentage of their reduction, the results revealed a significant decrease (P ≤ 0.05) (P ≤ 0.01) in numbers, weights and diameters of hydatid cysts in treated mice, expressed by the percentage reduction elevation of their numbers to (98%) in mice treated intraperitoneally (2-5 months) post infection, and 95% in mice treated orally 3 months pre infection, as compared with the control groups.

Cómo citar

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, T. T. E. (2019). Use of Lactobacillus rhamnosus GG Agaist Infection with Secondary Hydatid Disease in Swiss BABA/c Mice. https://doi.org/10.33899/edusj.2019.162974

MLA

al, Tasneem Torki et. "Use of Lactobacillus rhamnosus GG Agaist Infection with Secondary Hydatid Disease in Swiss BABA/c Mice." 2019. https://doi.org/10.33899/edusj.2019.162974.

Chicago

al, Tasneem Torki et. 2019. "Use of Lactobacillus rhamnosus GG Agaist Infection with Secondary Hydatid Disease in Swiss BABA/c Mice.". https://doi.org/10.33899/edusj.2019.162974.

Harvard

al, T. T. E. 2019, Use of Lactobacillus rhamnosus GG Agaist Infection with Secondary Hydatid Disease in Swiss BABA/c Mice, University of Mosul, College of Education for Pure Science, available at: https://doi.org/10.33899/edusj.2019.162974 [Accessed 30 Jun. 2026].

Compartir e imprimir

Guardá la ficha, copiá su enlace permanente o imprimila como PDF.

Exportar referencia

Si usás un gestor bibliográfico, podés exportar el registro en los formatos más comunes.

RIS BibTeX

Detalles del recurso

Información bibliográfica útil para confirmar que se trata del material correcto.

Título: Use of Lactobacillus rhamnosus GG Agaist Infection with Secondary Hydatid Disease in Swiss BABA/c Mice

Autor / colaboradores: Tasneem Torki et al

Editorial: University of Mosul, College of Education for Pure Science

Año de publicación: 2019

ISSN: 1812-125X

ISSN: 1812-125X

Idioma: eng

Materias

Explorá otros recursos relacionados a partir de estas materias.

probiotics; lactobaciuus rhamnosus; hydatid disease; echinococcus granulosus